Curus
Curus is a privately held Swedish investment company founded in 2021 that acquires and builds Nordic healthcare and digital-health companies, anchored by its wholly owned Add Health Media (medical communications to ~60,000 Nordic doctors) and Health Amplify (Sweden's largest e-prescribing platform used by 30,000+ doctors).
- Company typePrivate
- Founded2021
- HeadquartersStockholm, Sweden
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Curus does
Curus AB is a privately held Swedish investment holding company founded in 2021 and headquartered in Stockholm, focused on healthcare and digital-health companies across the Nordic region. The firm invests in both early and later stages in companies with SEK 10-200 million of turnover, taking both minority and majority stakes, with a stated objective to double the size of each portfolio company within five years. Curus manages 6 majority-owned and 22 minority growth-stage investments and is led by founder-CEO Johan Bloom alongside Investment Manager Erik Olsson Nyrinth and a board that includes the chairman Anna Dalgaard and PE executives affiliated with Nordic Capital and EQT. Capital is sourced primarily from family/PE-style investors led by Alfvén & Didrikson, with additional backers including the founders of Impilo and Versteegh Group.
Curus's operating value resides primarily in its wholly owned subsidiary Add Health Media, the Nordic region's leading medical-communications media house, which operates platforms such as PraktiskMedicin.se, Doktorn.com, Väntrums-TV, Onkologi i Sverige, Neurologi i Sverige, and Pharma Industry Publishing. The group also owns Health Amplify AB, whose e-Förskrivning platform is Sweden's largest e-prescribing system (over 30,000 doctors, more than 60% of Swedish medical professionals) and integrates with the National Medication List (NLL), Läkemedelsverket's NMI registry, the Swedish eHealth Agency, and the Sambi trust federation. Recent inorganic moves include Add Health Media's 2025 acquisition of Danish BestPractice Nordic (creating a ~60,000-doctor Nordic reach across SE/DK/NO/FI), the 2026 acquisition of AICD.nu (ICD-10/KVÅ clinical coding), and the May 2026 launch of the new e-Förskrivning platform.
The business model combines (i) investment returns via capital appreciation, dividends, and exit proceeds from a portfolio spanning 28+ healthcare companies; (ii) portfolio-company operations, principally advertising-supported medical communications and digital health platforms under Add Health Media; and (iii) transactional, partnership, and licensing revenue from clinical workflows (e-prescribing, lab testing marketplace Measurlabs, preventive health programs such as the Health Integrator/Region Stockholm health bond). Pricing is negotiated deal-by-deal at the holding level; portfolio services generally rely on B2B enterprise sales, advertising to pharma, and direct-to-provider mobile/web distribution.
Curus firmographics
Firmographics- Name
- Curus
- Legal name
- Curus AB
- Website
- https://curus.se
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Curus is a privately held Swedish investment company founded in 2021 that acquires and builds Nordic healthcare and digital-health companies, anchored by its wholly owned Add Health Media (medical communications to ~60,000 Nordic doctors) and Health Amplify (Sweden's largest e-prescribing platform used by 30,000+ doctors).
- Ownership category
- akta.pro rank
Where Curus is headquartered
LocationHeadquarters
- HQ city
- Stockholm
- HQ country
- Sweden
- HQ region
- Europe
Offices1 record
Markets served
Curus business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Investment Returns: Returns generated through capital appreciation, dividends, and exit proceeds from portfolio companies. Curus invests in both early and late-stage healthcare companies across the Nordic region.
- Portfolio Company Operations: Add Health Media (wholly owned) generates revenue through advertising to healthcare professionals, medical communications, and digital health services including e-prescribing platforms.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Curus product offering
Product offeringCore offering
Curus is a Swedish investment holding company that invests in and acquires Nordic healthcare companies, providing growth capital, strategic advisory, industry expertise and network access to portfolio companies. It owns and operates a portfolio of majority-controlled subsidiaries including Add Health Media (Nordic medical communications), Health Amplify (Sweden's largest e-prescription platform) and Pharma Industry Publishing, alongside minority stakes in digital health companies spanning mental health, obesity care, ADHD support, laboratory testing and medical staffing.
Product overview
Curus is a Swedish investment company founded in 2021, specializing in healthcare investments across the Nordic region. Rather than a single unified product, Curus operates a portfolio of companies and platforms in digital health. The core subsidiary is Add Health Media (wholly owned), which provides medical communication platforms including e-Förskrivning (e-Prescribing), Praktisk Medicin, DOKTORN.com, Väntrums-TV, and scientific journals. Other majority-owned companies include Health Amplify (e-prescription platform serving over 60% of Swedish doctors), Pharma Industry Publishing, Activate (rehab clinics), and Belly Balance (IBS treatment). Minority portfolio companies span mental health (Mindler), obesity care (Eatit), laboratory services (Measurlabs), supplements (Wellon), ADHD support (Ment), women's health (Ella), medical training (Vitala), dementia care (Geras Solutions), healthcare staffing (Colivia), digital care platforms (Healthmakers/Kura Vård, Curoflow), medical marketplace (Dropmed), child care (Knodd), medical device post-market surveillance (Knologram/Rekonnect), and preventive health (Health Integrator). Curus invests in companies with SEK 10-200 million turnover and aims to double portfolio company size within five years.
Differentiator
Problem solved
Functional benefit
Brands
- Add Health Media: The Nordic region's leading media house for health and medicine. Operates platforms including Doktorn.com, Praktisk Medicin, Väntrums-TV, e-Förskrivning, scientific journals Onkologi i Sverige and Neurologi i Sverige, and the industry forum Pharma Industry.
- Health Amplify
- Pharma Industry Publishing
Products and services
- Nordic Healthcare Growth Investment Services Long-term growth capital, strategic advisory, industry expertise and network access provided to Nordic healthcare companies with SEK 10-200 million turnover, taking both majority and minority equity positions. Aimed at founders and management teams of growth-stage healthcare companies seeking a long-term partner.
- Add Health Media Nordic medical communications group wholly owned by Curus. Operates platforms PraktiskMedicin.se, Onkologi i Sverige, Neurologi i Sverige, Doktorn.com, Väntrums-TV, Pharma-Industry.se and BestPractice Nordic, reaching healthcare professionals and patients across Denmark, Norway, Sweden and Finland.
- e-Förskrivning (e-Prescribing platform)
Quantifiable outcome
- Reach nearly 60,000 validated doctors across Nordic region
- +3 more outcomes
Companies that use Curus
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Curus technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration8 records
Feature4 records
Curus partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered minor and core.
- Novo NordiskminorCollaboration with portfolio company Eatit to increase awareness of obesity and promote prevention in Swedish healthcare. Includes development project to strengthen preventive efforts and increase disease knowledge.
- Region StockholmcoreCollaboration on preventive healthcare initiative targeting type 2 diabetes prevention. Region Stockholm financed the program through a health bond, with Health Integrator providing the digital platform.
- Läkemedelsverket (Swedish Medical Products Agency)coreHealth Amplify's e-Prescribing platform registered as National Medical Information System (NMI) with the agency.
- E-hälsomyndigheten (Swedish eHealth Agency)corePlatform approved for connection to National Medication List (NLL) by the Swedish eHealth Agency.
- SambicoreHealth Amplify is a trusted partner of Sambi, with both company and platform trust-assured and approved within the Sambi federation.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Curus competitors and assessment
Company assessmentDirect peers
- Impilo: Norwegian/Nordic private equity firm focused exclusively on healthcare investments. Highly comparable to Curus as a Nordic healthcare-focused PE; notably, Impilo's founder Fredrik Strömholm is a Curus investor, reinforcing direct strategic overlap.
- HealthCap: Swedish healthcare-focused venture and growth investor with a long track record in Nordic life sciences and digital health. Comparable to Curus in Nordic healthcare-only mandate and growth-stage focus.
- Karolinska Development: Swedish investment company focused on Nordic life sciences and digital health, with a publicly listed structure and portfolio of growth-stage healthcare companies. Highly comparable investment holding model to Curus.
- MTIP: Swiss-based European growth investor specializing in digital health and HealthTech. Comparable as a focused digital-health growth investor, though with broader European (not Nordic-only) mandate.
- Sunstone Capital: Danish/Nordic life science and healthtech venture capital firm. Comparable to Curus in Nordic healthcare focus and growth-stage digital health investing, though venture-stage rather than buyout.
Broad incumbents
- EQT Life Sciences: European healthcare and life sciences growth investor under EQT, a major Nordic-rooted PE firm. Johan Dettel, a Curus investor, is a former EQT partner, evidencing network overlap; EQT Life Sciences targets larger-scale healthcare opportunities than Curus.
- Nordic Capital: Major Nordic-rooted private equity firm with significant healthcare exposure. Klas Tikkanen (COO/partner at Nordic Capital) is a Curus investor, demonstrating strong network adjacency; Curus operates at a much smaller scale than Nordic Capital funds.
- AddLife: Swedish-listed company focused on life science and healthcare distribution/platform acquisitions. Comparable as a Nordic healthcare consolidator with a buy-and-build strategy, though focused on distribution/specialty products rather than digital health platforms.
Regional players
- Lauxera Capital Partners: European healthcare-focused PE firm with a buy-and-build platform strategy in healthcare services and technology. Comparable in healthcare-only focus and consolidation playbook, though focused on broader Europe rather than Nordic.
- Trill Impact: Nordic-rooted impact-focused private equity firm with healthcare exposure. Comparable in Nordic footprint and growth-stage mandate, though broader sector mandate including impact themes beyond healthcare.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Curus compliance and trust
Trust signalCompliance6 records
Curus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Curus leadership team
Management profileNumber of profiles
Profiles5 records
Curus subsidiaries and ownership
Company hierarchySubsidiaries5 records
Curus funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Curus M&A and investment
M&A and investmentM&A
Investments5 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Curus
What does Curus do?
Curus is a Swedish investment holding company that invests in and acquires Nordic healthcare companies, providing growth capital, strategic advisory, industry expertise and network access to portfolio companies. It owns and operates a portfolio of majority-controlled subsidiaries including Add Health Media (Nordic medical communications), Health Amplify (Sweden's largest e-prescription platform) and Pharma Industry Publishing, alongside minority stakes in digital health companies spanning mental health, obesity care, ADHD support, laboratory testing and medical staffing.
Is Curus a public or private company?
Curus is a private company. It is classified as venture growth investor backed and is currently operating.
When was Curus founded?
Curus was founded in 2021. It employs 11 to 50 people.
Where is Curus based?
Curus is headquartered in Stockholm, Sweden, in the Europe region.
How does Curus make money?
Two revenue lines are on record. Investment Returns are the primary driver. The others are portfolio Company Operations.
Who are Curus's main competitors?
Direct peers on record are Impilo, HealthCap, Karolinska Development, MTIP and Sunstone Capital. Broad incumbents are EQT Life Sciences, Nordic Capital and AddLife. Regional players are Lauxera Capital Partners and Trill Impact.
Does Curus have an API?
No public API is recorded for Curus.